Madrigal Pharmaceuticals, Inc. (MDGL)

NASDAQ: MDGL · Real-Time Price · USD

541.08

-1.53 (-0.28%)

At close: Sep 4, 2026, 4:00 PM EDT

541.33

+0.25 (0.05%)

After-hours: Sep 4, 2026, 7:30 PM EDT

Madrigal Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	292.73	198.69	100.02	99.92	331.55	36.27
Short-Term Investments	546.03	784.87	826.23	534.22	27.23	234.08
Cash & Short-Term Investments	838.75	983.56	926.25	634.13	358.77	270.35
Cash Growth	5.24%	6.19%	46.07%	76.75%	32.71%	-4.86%
Accounts Receivable	192.31	134.48	53.82	-	-	-
Receivables	192.31	134.48	53.82	-	-	-
Inventory	99.39	74.84	34.07	-	-	-
Prepaid Expenses	68.57	47.8	13.79	3.15	2.6	1.34
Restricted Cash	0.16	5.09	5	-	-	-
Total Current Assets	1,199	1,246	1,033	637.28	361.37	271.68
Property, Plant & Equipment	17.17	6.44	4.59	3.27	1.2	1.65
Other Intangible Assets	7.19	7.38	4.73	-	-	-
Total Assets	1,245	1,260	1,042	640.55	362.57	273.33

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	34.51	48.88	43.6	28.04	23.83	21.38
Accrued Expenses	338.66	260.39	124.7	89.98	91.46	55.05
Current Portion of Leases	1.03	1.02	0.98	0.53	0.6	0.41
Total Current Liabilities	374.2	310.29	169.28	118.55	115.89	76.84
Long-Term Debt	340.79	339.88	117.57	115.48	49.29	-
Long-Term Leases	5.92	6.73	1.02	1.19	-	0.39
Total Liabilities	720.92	656.9	287.86	235.21	165.18	77.23

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	2,766	2,692	2,556	1,741	1,160	863.5
Retained Earnings	-2,243	-2,090	-1,802	-1,336	-962.66	-667.31
Comprehensive Income & Other	0.81	0.87	0.47	0.47	-0.03	-0.08
Shareholders' Equity	523.72	602.69	754.38	405.33	197.39	196.11
Total Liabilities & Equity	1,245	1,260	1,042	640.55	362.57	273.33

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	347.75	347.63	119.57	117.19	49.89	0.8
Net Cash (Debt)	491	635.93	806.68	516.94	308.88	269.55
Net Cash Growth	-27.05%	-21.17%	56.05%	67.36%	14.59%	-4.88%
Net Cash Per Share	21.47	28.35	37.92	27.66	18.02	16.30
Filing Date Shares Outstanding	23.1	22.94	22.08	19.9	18.14	17.1
Total Common Shares Outstanding	23.09	22.84	22	19.88	18.1	17.1
Working Capital	824.98	935.48	863.65	518.73	245.48	194.85
Book Value Per Share	22.68	26.39	34.28	20.39	10.90	11.47
Tangible Book Value	516.54	595.31	749.65	405.33	197.39	196.11
Tangible Book Value Per Share	22.37	26.06	34.07	20.39	10.90	11.47

SEC Filings: 10-K · 10-Q